Remifentanil
Remifentanil, Ultiva (remifentanil) is a small molecule pharmaceutical. Remifentanil was first approved as Ultiva on 1996-07-12. It is used to treat pain in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Remifentanil, Ultiva
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| remifentanil hydrochloride | ANDA | 2025-02-13 |
| remifentanil hydrochloride remifentanil hydrochloride | ANDA | 2020-10-16 |
| ultiva | New Drug Application | 2023-12-21 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| pain | EFO_0003843 | D010146 | R52 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
1073 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anesthesia | D000758 | — | — | 3 | 4 | 13 | 31 | 78 | 127 |
| Postoperative pain | D010149 | — | G89.18 | — | 2 | 3 | 27 | 52 | 84 |
| General anesthesia | D000768 | — | — | — | 1 | 3 | 10 | 50 | 64 |
| Pain | D010146 | EFO_0003843 | R52 | 4 | — | 1 | 14 | 33 | 52 |
| Intravenous anesthesia | D000771 | — | — | — | — | 2 | 9 | 25 | 36 |
| Emergence delirium | D000071257 | — | — | 2 | 1 | 1 | 8 | 24 | 35 |
| Delirium | D003693 | — | R41.0 | 2 | — | 1 | 7 | 19 | 29 |
| Analgesia | D000698 | — | — | — | — | 3 | 4 | 19 | 26 |
| Hyperalgesia | D006930 | — | — | 1 | 3 | 1 | 11 | 9 | 25 |
| Agnosia | D000377 | EFO_0007136 | F88 | — | 1 | 3 | 5 | 6 | 15 |
Show 198 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Wounds and injuries | D014947 | — | T14.8 | — | — | 1 | — | 9 | 10 |
| Ischemic stroke | D000083242 | — | — | — | — | 1 | — | 6 | 7 |
| Anesthesia and analgesia | D000760 | — | — | — | 1 | 2 | — | 3 | 5 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | — | 4 | 5 |
| Septic shock | D012772 | — | A48.3 | — | — | 2 | — | 2 | 4 |
| Inflammation | D007249 | MP_0001845 | — | — | — | 1 | — | 3 | 4 |
| Scoliosis | D012600 | EFO_0004273 | M41 | — | 2 | 1 | — | 1 | 4 |
| Muscle hypotonia | D009123 | — | — | — | 1 | 1 | — | 1 | 3 |
| Laryngismus | D007826 | — | J38.5 | — | — | 1 | — | 2 | 3 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 1 | 1 | — | 1 | 3 |
Show 24 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 4 | 5 |
| Hysterectomy | D007044 | EFO_0003881 | — | — | 1 | — | — | 3 | 4 |
| Spinal fusion | D013123 | — | — | — | 1 | — | — | 1 | 2 |
| Low back pain | D017116 | — | M54.5 | — | 1 | — | — | — | 1 |
| Spondylolisthesis | D013168 | EFO_0007493 | M43.1 | — | 1 | — | — | — | 1 |
| Morphine dependence | D009021 | EFO_0005612 | — | — | 1 | — | — | — | 1 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | — | — | — | 1 |
| Fibrosis | D005355 | — | — | — | 1 | — | — | — | 1 |
| Hallux valgus | D006215 | — | — | — | 1 | — | — | — | 1 |
| Eclampsia | D004461 | — | O15 | — | 1 | — | — | — | 1 |
Show 6 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | 8 | 9 |
| Femur head necrosis | D005271 | — | — | 1 | — | — | — | — | 1 |
| Necrosis | D009336 | — | — | 1 | — | — | — | — | 1 |
| Opiate overdose | D000083682 | — | — | 1 | — | — | — | — | 1 |
| Tympanic membrane perforation | D018058 | — | H72 | 1 | — | — | — | — | 1 |
| Postoperative care | D011182 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 9 | 9 |
| Prostatic neoplasms | D011471 | — | C61 | — | — | — | — | 7 | 7 |
| Colorectal neoplasms | D015179 | — | — | — | — | — | — | 7 | 7 |
| Pharyngitis | D010612 | — | R07.0 | — | — | — | — | 6 | 6 |
| Patient satisfaction | D017060 | — | — | — | — | — | — | 5 | 5 |
| Female genital diseases | D005831 | EFO_0009549 | N85 | — | — | — | — | 5 | 5 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 5 | 5 |
| Ischemia | D007511 | EFO_0000556 | — | — | — | — | — | 5 | 5 |
| Hypoxia | D000860 | — | R09.02 | — | — | — | — | 4 | 4 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | — | — | 4 | 4 |
Show 225 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Remifentanil |
| INN | remifentanil |
| Description | Remifentanil is a piperidinecarboxylate ester that is methyl piperidine-4-carboxylate in which the hydrogen attached to the nitrogen is substituted by a 3-methoxy-3-oxopropyl group and the hydrogen at position 4 is substituted the nitrogen of N-propanoylaniline. It has a role as a mu-opioid receptor agonist, an opioid analgesic, an intravenous anaesthetic and a sedative. It is an anilide, a piperidinecarboxylate ester, a monocarboxylic acid amide and an alpha-amino acid ester. |
| Classification | Small molecule |
| Drug class | narcotic analgesics (fentanyl derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1 |
Identifiers
| PDB | — |
| CAS-ID | 132875-61-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1005 |
| ChEBI ID | 8802 |
| PubChem CID | 60815 |
| DrugBank | DB00899 |
| UNII ID | P10582JYYK (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 21,171 documents
View more details
Safety
Black-box Warning
Black-box warning for: Remifentanil hydrochloride, Remifentanil hydrochloride remifentanil hydrochloride, Ultiva
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
3,980 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use